Your Messages Inbox
Your Article Summary
See Latest ArticlesNew Delivery System for RELISTOR in Pre-Filled Syringes Submitted for U.S. and European Marketing Approval
Wyeth, 08/06/09
Progenics Pharmaceuticals, Inc. and Wyeth Pharmaceuticals, a division of Wyeth, announced submission of a supplemental New Drug Application to the United States Food and Drug Administration and an Extension Application to the European Union European Medicines Agency for RELISTOR subcutaneous injection for a new delivery system, pre–filled syringes. RELISTOR was approved last year in single–use vials. RELISTOR is indicated for the treatment of opioid–induced constipation in patients with advanced illness who are receiving palliative care, when response to laxative therapy has been insufficient. If approved, pre–filled syringes of RELISTOR are expected to be available in the U.S. and Europe as early as the first half of 2010.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread(R) for Chronic Hepatitis B in Key Asian Countries
Gilead, 11/25/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
Medtronic Introduces 3D Recon Service to Enhance Endovascular Treatment of Aortic Aneurysms
Medtronic, 11/20/09
Article Search
Sponsor